Graham Exelby
Nigella Sativa in COVID
Black seed or N. sativa that belongs to the Ranunculacea family has a rich historical and religious background. It is native to southwest...
top of page
Long COVID
Research in COVID-19 has answered many of the questions that kept popping up in POTS, Fibromyalgia and similar conditions- how a virus (or trauma, mould, parasites, sustained stress) can activate threat receptors (Toll-like receptors, or TLRs) which then activate Mast Cells that are responsible for the cytokine storm that is what happens in COVID.
Graham Exelby
- Nov 7, 2022
Introduction to Long Covid
Dr Graham Exelby MB BS Uni of Qld Dr Valerio Vittone PhD Medicine (SYD 2008) BSc Hons (UNSW): Topic: Virology and Molecular Biology....
Graham Exelby
- Nov 6, 2022
Long Covid Part 1: Overview
Dr Graham Exelby, Dr Valerio Vittone. Updated February 2023 Introduction Coronavirus disease 2019 (COVID-19) is emerging as the greatest...
Graham Exelby
- Nov 2, 2022
Long Covid Part 3: The Infection
Dr Graham Exelby January 2023 The SARS-CoV-2 virus is transmitted via respiratory droplets and aerosols from person to person. The...
Graham Exelby
- Nov 1, 2022
Long Covid Part 4. The Immune Response, Toll-Like Receptors and the Cytokine Storm
Dr Graham Exelby Updated February 2023 Manek and Singh(245) describe: “A balanced immune regulation is crucial for recognizing an...
Graham Exelby
- Oct 26, 2022
Long Covid Part 6 Mast Cell Activation
Dr Graham Exelby Updated February 2023 Summary: The major cause of morbidity and mortality in Covid-19 patients is from an exaggerated...
Graham Exelby
- Oct 24, 2022
Long Covid Part 7 – Long Covid
Dr Graham Exelby Updated February 2023 What is Long COVID? Introduction: While the acute impacts of COVID-19 were the initial focus of...
Graham Exelby
- Oct 23, 2022
Long COVID Part 8: POTS and Autonomic Dysfunction
Dr Graham Exelby January 2023 The major cause of morbidity and mortality in COVID-19 patients is from an exaggerated immune response...
Graham Exelby
- Oct 21, 2022
Long Covid Part 9: Management
Dr Graham Exelby January 2023 Management described below does not include the specialized programs in the severely impaired patients. ...
Graham Exelby
- Oct 18, 2022
Long Covid Part 10: The Mermaid Beach Protocol
February 2023 Introduction: This protocol has been developed at our clinic at Mermaid Beach. It is designed to be used in association...
Valerio Vittone
- Oct 16, 2022
Long Covid Part 11 The Genetic Basis to Improving Toxin Detoxification
Your genetics determine if the body can clear toxins efficiently. Dr Valerio Vittone (PH.D) January 2023 Clearance of toxic compounds...
Graham Exelby
- Oct 15, 2022
Long COVID Acknowledgements and References
Acknowledgements: Dr Valerio Vittone, PH.D (biochemistry, molecular biology and virology) for his ongoing research into the underlying...
Graham Exelby
- Oct 14, 2022
Long Covid Part 12 The Glymphatic System and mechanical factors affecting Brain Fog
Dr Graham Exelby January 2023 This paper combines the research in multiple areas to find the driving pathology in diverse areas...
Graham Exelby
- Oct 12, 2022
Breaking Through in Long Covid and POTS
Research in COVID-19 has answered many of the questions that kept popping up in POTS, Fibromyalgia and similar conditions- how a virus...
Graham Exelby
- Oct 11, 2022
Long Covid Part 13 Low Dose Naltrexone and MCAS Treatment
Adapted with approval from Dr Jill Carnahan: Dr Graham Exelby January 2023 https://www.jillcarnahan.com/2019/04/25/9-proven-treatments-fo...
bottom of page